Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene.
about
Reactive oxygen species and silica-induced carcinogenesisCyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapyCyclooxygenase-2 is a neuronal target gene of NF-kappaBFunctional role of NF-IL6beta and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene.Selective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblastsSuppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylateCyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in miceUpregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-kappa B and I kappa B kinase-alpha in human colorectal cancer epithelial cellscPGES/p23 is required for glucocorticoid receptor function and embryonic growth but not prostaglandin E2 synthesisFlexibility of the NSAID binding site in the structure of human cyclooxygenase-2Sirt1 activation protects the mouse renal medulla from oxidative injury.Divergent responses to peptidoglycans derived from different E. coli serotypes influence inflammatory outcome in trout, Oncorhynchus mykiss, macrophages.Gallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes.Human glutathione dependent prostaglandin E synthase: gene structure and regulation.Regulation of bombesin-stimulated cyclooxygenase-2 expression in prostate cancer cells.Androgenetic alopecia and microinflammation.Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonismDynamic regulation of cyclooxygenase-2 promoter activity by isoforms of CCAAT/enhancer-binding proteins.Transcriptional regulation of cyclooxygenase-2 in response to proteasome inhibitors involves reactive oxygen species-mediated signaling pathway and recruitment of CCAAT/enhancer-binding protein delta and CREB-binding proteinCyclooxygenase- and lipoxygenase-mediated DNA damage.Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1Rev-erbalpha upregulates NF-kappaB-responsive genes in vascular smooth muscle cells.Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells.Epidermal growth factor and interleukin-1beta utilize divergent signaling pathways to synergistically upregulate cyclooxygenase-2 gene expression in human amnion-derived WISH cellsThe camptodactyly-arthropathy-coxa vara-pericarditis syndrome: clinical features and genetic mapping to human chromosome 1.Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation.Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1beta in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone h4 acetylation.Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.Rosmarinic acid antagonizes activator protein-1-dependent activation of cyclooxygenase-2 expression in human cancer and nonmalignant cell lines.Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics.Role of the progesterone receptor (PR) in the regulation of inflammatory response pathways and aromatase in the breast.The effect of lipopolysaccharide on enhanced inflammatory process with age: Modulation of NF-κB.Extending Immunological Profiling in the Gilthead Sea Bream, Sparus aurata, by Enriched cDNA Library Analysis, Microarray Design and Initial Studies upon the Inflammatory Response to PAMPsDNA damage-induced cytotoxicity is mediated by the cooperative interaction of phospho-NF-κB p50 and a single nucleotide in the κB-site.Cyclooxygenase-2 and its regulation in inflammation.Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study.Structure of the 5'-flanking regulatory region of the mouse gene encoding the clearance receptor for atrial natriuretic peptide.The ETS-Domain Transcription Factor Elk-1 Regulates COX-2 Gene Expression and Inhibits Glucose-Stimulated Insulin Secretion in the Pancreatic β -Cell Line INS-1.Timosaponin AIII Suppresses Hepatocyte Growth Factor-Induced Invasive Activity through Sustained ERK Activation in Breast Cancer MDA-MB-231 Cells.Increased cyclooxygenase-2 expression in juvenile polyposis syndrome.
P2860
Q23923891-BEC485F6-E596-4FD4-AA4C-1EC68A93121DQ24675327-D166D366-4D83-4FD0-9A7F-EF1B2AD0B761Q24795366-0930F234-FD95-40FD-9511-E85964E754AFQ25257455-2C8FA9A6-09DF-48FA-8F55-16E9F372B36AQ28181159-0FEABF20-E4CE-458E-BD47-0A996F377744Q28343291-30E772DD-4AA3-4C6A-A4BB-15928A1F5228Q28362073-C4E277D2-ABA6-472E-99C9-46968B9C9E59Q28384366-EAB73038-5F27-4AF8-BC99-71BE80FD1309Q28588095-45305088-B6E5-4F63-B468-1DF171789BB2Q28623540-868E49CB-D8B7-42DE-BC8C-006C435974D7Q33755433-9272D350-B195-45EA-8CF7-A56AC94DFAAEQ33793488-44400F6B-0569-487B-9A1F-9033AA4CCD2EQ33808898-C3E18600-655E-43DD-B6D7-EF192DDD00ACQ33897775-601A7AF8-75C7-4749-B663-274C85FC6A13Q33957249-758BC90B-2612-4595-A058-7D12A3935CDFQ34022630-5EEA62B7-715B-4686-9BF4-01D613F6F96CQ34079481-753DC2DE-6B3E-440C-9453-05FCC462FDB4Q34104923-6AFE696B-77FC-4CC8-972C-AEE78830C72CQ34148151-3BFC888A-7299-458D-B922-893C5B08986CQ34225293-76699447-7055-472E-9B6B-73E385AB6B78Q34302223-415DCB70-3CFD-4DAD-BC06-BD689F527DF7Q34304772-12E0D54D-7252-4A73-AE80-F87D273292DFQ34335269-A455C8AF-8E98-4138-9132-746C46725D4CQ34424726-45EAF93C-2B49-4815-9520-2996ECF52AC7Q34464837-792B0A2B-5DFD-47FB-9BA3-6A23109934BAQ34568343-342A62B9-0D31-425E-B577-515631CA73BBQ34986711-3D48EC88-D710-44E4-8D4A-3A5404E723CCQ35147941-6FCB976D-0209-4F9F-9EAD-ECB1A927D7EFQ35151349-6616C7DF-FFE5-4F83-890A-20A2AA2285CEQ35652193-F2B99C45-F0F9-4146-AFD0-967C34C98451Q35839056-B58C8551-C670-446A-9B09-1944B5B95248Q36269874-2DBA214F-726F-480B-90B6-B9D3091948BCQ36271344-8E565FA9-D939-4420-8122-19AA6353D2EFQ36559233-685FCF65-658A-47F4-BB82-EBA267781399Q36628126-B902DEE6-E047-4746-A869-25DCE91C85D7Q36695052-C8449E28-19E1-4EA0-89E7-580E46BF13E8Q36797914-902F0A5D-B0C2-413A-ACA1-C01473087B95Q36933418-E99DCAAF-17D0-474D-AC79-56CB1B7FDB5FQ37002873-795285C1-E434-463D-B4CB-11406661A314Q37232962-426E934C-DD0C-4C9D-94F3-C3461DCB654F
P2860
Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Characterization of the genomi ...... ostaglandin H synthase-2 gene.
@ast
Characterization of the genomi ...... ostaglandin H synthase-2 gene.
@en
type
label
Characterization of the genomi ...... ostaglandin H synthase-2 gene.
@ast
Characterization of the genomi ...... ostaglandin H synthase-2 gene.
@en
prefLabel
Characterization of the genomi ...... ostaglandin H synthase-2 gene.
@ast
Characterization of the genomi ...... ostaglandin H synthase-2 gene.
@en
P2093
P356
P1476
Characterization of the genomi ...... ostaglandin H synthase-2 gene.
@en
P2093
P304
P356
10.1006/BBRC.1994.2167
P407
P577
1994-08-01T00:00:00Z